AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $15K-$50K of Merck & Company, Inc. (MRK) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of Merck & Company, Inc. (MRK) stock worth $15K-$50K in a STOCK Act filing on Feb 10, 2025.
The trade happened on Jan 27, 2025, 14 days before it was made public.
MRK has moved +47.3% since the trade date, from $97.94 to $144.30 (Oct 2, 2026 close).
- Traded
- Jan 27, 2025
- Disclosed
- Feb 10, 2025
- Filing delay
- 14 days
- Price since
- +47.3%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyABEV$1K-$15KFeb 10, 2025
- BuyABT$1K-$15KFeb 10, 2025
- BuyABT$1K-$15KFeb 10, 2025
- SellANET$1K-$15KFeb 10, 2025
- SellANET$1K-$15KFeb 10, 2025
- SellAVGO$1K-$15KFeb 10, 2025
- SellAVGO$1K-$15KFeb 10, 2025
- BuyBRK.B$1K-$15KFeb 10, 2025
- BuyCDRE$1K-$15KFeb 10, 2025
- BuyD$1K-$15KFeb 10, 2025
- BuyDHI$1K-$15KFeb 10, 2025
- SellETN$1K-$15KFeb 10, 2025
- SellETN$1K-$15KFeb 10, 2025
- SellFICO$1K-$15KFeb 10, 2025
- BuyGBOOY$1K-$15KFeb 10, 2025
- BuyGLW$1K-$15KFeb 10, 2025
- BuyGLW$1K-$15KFeb 10, 2025
- BuyGMAB$1K-$15KFeb 10, 2025
- SellGOOG$1K-$15KFeb 10, 2025
- SellICFI$1K-$15KFeb 10, 2025
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.